Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic lymphocytes (1 trial)
azacitidine (vidaza) (1 trial)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Preleukemia (Phase 2)
Recurrence (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (2 total)